All posts in Blood cancer research

Dr Ashwin U

Improving the “wait and see” approach to treatment for high-risk blood cancer

Australian researchers utilising valuable samples from an initial clinical trial funded with the help of Leukaemia Foundation supporters have discovered why half of patients with a type of high-risk blood cancer will not respond to a common treatment. The discovery could form the basis for a world-first clinical test to identify early whether or not […]

Committed to investing in research and providing free support to improve the lives of those living with blood cancer
Researchers-paired

Brightest blood cancer minds come to Queensland

Some of Australia’s leading blood cancer researchers came to Brisbane earlier this year to share fascinating insights and knowledge that will help the state’s researchers beat blood cancer. Thanks to our supporters, we were able to help bring Professor Fabienne Mackay from the University of Melbourne and Associate Professor John Pimanda from the University of New South […]

Committed to investing in research and providing free support to improve the lives of those living with blood cancer
Gandhi

Improving lymphoma outcomes with personal touch

A recent review of the latest medical advances for people with Hodgkin lymphoma has highlighted how personalised treatment is improving outcomes for patients. Professor Maher Gandhi, the Leukaemia Foundation Chair in Blood Cancer Research at The University of Queensland’s Diamantina Institute, said the new approaches were aimed at “minimising toxicity while maximising response”. He said […]

Committed to investing in research and providing free support to improve the lives of those living with blood cancer
Professor Maher Gandhi

No hair, Maher!

Professor Maher Gandhi is used to giving things up for blood cancer. As part of his role as our Chair in Blood Cancer Research at The University of Queensland Diamantina Institute, he’s given up a lot of his time and brain cells over the years to help beat blood cancer. So the clinical haematologist and researcher should be well-prepared […]

Committed to investing in research and providing free support to improve the lives of those living with blood cancer
research_blog

Examining the link between Down syndrome and blood cancer

People with Down syndrome have a heightened risk of developing a blood cancer or disorder, with research indicating an extra copy of a blood cell development gene might be responsible. The role of the gene, called the Erg gene, in predisposing to Down syndrome blood disorders is being examined by Dr Ashley Ng, a researcher at the […]

Committed to investing in research and providing free support to improve the lives of those living with blood cancer
blog-Rick-Pearson

New drug combination offers new hope to patients

The Leukaemia Foundation is proud to have funded four researchers at the Peter MacCallum Cancer Centre working on the development of a new drug, CX-5461, currently being evaluated in a clinical trial for patients with advanced blood cancers. Results from the trial have been promising to date, however the research team has found that CX-5461 could be even more […]

Committed to investing in research and providing free support to improve the lives of those living with blood cancer
Grabow-PD-2015

Targeting cancer ‘survival’ protein to kill cancer cells

A protein critical for the survival of many cancer cells, called MCL-1, might be the key to a new treatment for lymphoma and leukaemia patients. Leukaemia Foundation funded researcher Dr Stephanie Grabow and her team, in particular Drs Gemma Kelly and Brandon Aubrey at Melbourne’s Walter and Eliza Hall Institute of Medical Research, are investigating the […]

Committed to investing in research and providing free support to improve the lives of those living with blood cancer
Myeloma_Ankit-Dutta

Unravelling the genetic mysteries of myeloma

Despite being the third most common blood cancer affecting more than 1500 Australians each year, mystery surrounds the development of myeloma. What we do know is that in almost every case, myeloma develops from a benign (non-cancerous) disease known as monoclonal gammopathy of undetermined significance (MGUS). We just don’t know how. Looking at the genes […]

Committed to investing in research and providing free support to improve the lives of those living with blood cancer
Dean and Dawson lab

Working to understand and improve MDS drug

Azacitidine (Vidaza®) is the only drug available for treating myelodysplastic syndrome (MDS), and is also used to treat several other blood cancers. Unfortunately, the drug is only effective in about half of MDS cases, and its exact mode of action isn’t understood. With funding support from the Leukaemia Foundation, Dean Tyler at the University of Melbourne and Peter […]

Committed to investing in research and providing free support to improve the lives of those living with blood cancer
Maher_Web

A vital head start against cancer

Doctors will be given a valuable head start against cancer with the development of a new test that can identify the 40% of patients with an aggressive form of lymphoma who are not likely to respond to standard treatment. Our Chair in blood cancer research at UQ Diamantina Institute in Brisbane, Professor Maher Gandhi, explains the laboratory test and how […]

Committed to investing in research and providing free support to improve the lives of those living with blood cancer